XORTX Therapeutics Inc.
XRTX
$0.8001
$0.080111.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.83% | 70.31% | -53.53% | 90.09% | 79.69% |
| Total Depreciation and Amortization | -0.38% | 5.71% | -16.18% | -16.32% | -26.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.34% | -83.76% | 83.04% | -365.73% | -106.52% |
| Change in Net Operating Assets | -17.64% | 216.04% | 111.33% | 97.30% | 239.78% |
| Cash from Operations | 30.25% | 44.12% | 44.12% | 54.03% | 49.87% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.94% | -43.84% | 7.60% | -2.29% | 30.60% |
| Cash from Investing | -81.94% | -35.96% | 15.98% | 16.14% | 43.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -56.07% | -16.52% | -5.29% | -25.00% | -25.27% |
| Issuance of Common Stock | -20.01% | -20.01% | 1,172,266.67% | -59.66% | -59.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.29% | 33.00% | -126.18% | -431.23% | -119.92% |
| Cash from Financing | -18.80% | -16.20% | 869.73% | -73.47% | -70.84% |
| Foreign Exchange rate Adjustments | 128.89% | -300.00% | -978.05% | -71.43% | 84.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.70% | 52.36% | 86.06% | 27.20% | 27.40% |